Sri Shankara Cancer Foundation
Sri Shankara Cancer Foundation is a company.
Financial History
Leadership Team
Key people at Sri Shankara Cancer Foundation.
Sri Shankara Cancer Foundation is a company.
Key people at Sri Shankara Cancer Foundation.
Sri Shankara Cancer Foundation (SSCF) is a not-for-profit organization established in 2008, dedicated to combating cancer through high-quality, affordable treatment, prevention, research, and training.[1][2] It operates two state-of-the-art cancer hospitals—Sri Shankara Cancer Hospital & Research Centre in Bengaluru (established 2012) and Bagchi Sri Shankara Cancer Centre & Research Institute in Bhubaneswar (established 2024)—with a combined 1,270 beds, alongside institutions for cancer prevention research and healthcare training.[1][2] SSCF's mission is to pioneer cancer cure and research by ensuring accessible, evidence-based care for all, regardless of socio-economic status, through initiatives like free screenings, awareness programs, and support for underprivileged patients.[1][3]
The foundation emphasizes a holistic strategy: delivering affordable treatment, conducting outreach via programs like Sarva Rakshana (covering 6.5 lakh people with 74,083 screenings and free treatment for 146 detected cases), advancing oncology research, and training professionals via Sri Shankara College of Nursing and Institute of Allied Health Sciences.[1][2]
SSCF was conceived in 2008 by a group of forward-thinking individuals under the visionary leadership of Managing Trustee Dr. B.S. Srinath, a surgical oncologist with 50 years of experience.[2] The idea emerged from a commitment to provide inclusive, high-quality cancer care to underserved populations, alleviating physical, emotional, and financial burdens on patients and families.[2] Early milestones included establishing the Bengaluru hospital in 2012, expanding with specialized centers for prevention and training, and launching outreach tools like the 'Vidhaatri' cancer detection camp bus, supported by partners such as Cognizant Foundation.[1][2]
Pivotal growth came with the 2024 opening of the Bhubaneswar center, scaling capacity to 1,270 beds and amplifying impact through nationwide prevention efforts.[1] A U.S. affiliate, SSCF USA (registered 2011 as a 501(c)(3) non-profit), was formed to fund treatments for underprivileged patients and raise awareness via events.[4][5]
SSCF rides the trend of integrating advanced medical technology with preventive healthcare in oncology, leveraging innovations in diagnostics, cell culture, bioinformatics, and proteomics for early detection and personalized treatment.[1][8] Timing aligns with India's rising cancer burden—projected to surge due to aging populations and lifestyle factors—where accessible, tech-enabled care addresses gaps in rural and low-income access.[1][3] Market forces like growing philanthropy (e.g., Cognizant Foundation support) and global funding via SSCF USA favor scalable models combining AI-driven screenings with traditional outreach.[1][4]
The foundation influences India's healthcare ecosystem by training professionals, generating research for societal impact, and proving non-profits can deliver world-class care affordably, inspiring similar models and reducing national cancer mortality through prevention.[1][2]
SSCF is poised for expansion with its recent Bhubaneswar hospital and ongoing research hires (e.g., Ph.D. programs with MAHE), potentially scaling outreach to millions amid India's cancer epidemic.[1][8] Trends like telemedicine integration, AI for risk prediction, and partnerships for drug screening will shape its path, enhancing early detection in underserved regions.[1][8] Its influence may evolve by setting benchmarks for non-profit oncology, exporting training models globally, and pioneering affordable precision medicine—reinforcing its role as a leader ensuring "high-quality care reaches the common man."[3] This trajectory builds on its proven impact, transforming cancer from a death sentence to a manageable condition for the masses.[1][2]
Key people at Sri Shankara Cancer Foundation.